STOCK TITAN

Amanat Acquisition Corp Announces Pricing of $75 Million Initial Public Offering

(Neutral)
(Neutral)
Tags

Amanat Acquisition Corp (Nasdaq: AMAN) priced its $75 million initial public offering, offering 7,500,000 Class A ordinary shares at $10.00 per share. Trading on the Nasdaq Capital Market begins May 19, 2026, with closing expected May 20, 2026, subject to customary conditions.

The Cayman Islands-based SPAC plans to pursue a business combination, primarily targeting healthcare and healthcare-related industries. Leerink Partners is sole bookrunning manager, with a 45-day option to buy up to 1,125,000 additional shares to cover over-allotments.

Loading...
Loading translation...

Positive

  • $75 million IPO via 7,500,000 shares at $10.00 each
  • Listing on Nasdaq Capital Market under ticker AMAN
  • 45-day option for 1,125,000 additional shares to cover over-allotments
  • Effective SEC registration statement dated May 18, 2026

Negative

  • Potential shareholder dilution from 1,125,000-share over-allotment option

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WESTFIELD, N.J., May 19, 2026 (GLOBE NEWSWIRE) -- Amanat Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 7,500,000 Class A ordinary shares at an offering price of $10.00 per share. The Class A ordinary shares are expected to trade on the Nasdaq Capital Market under the ticker symbol “AMAN” beginning today. The offering is expected to close on May 20, 2026, subject to customary closing conditions.

The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries.

Leerink Partners is acting as sole bookrunning manager. The Company has granted the underwriter a 45-day option to purchase up to 1,125,000 additional Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.

A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on May 18, 2026 (the “Effective Date”). The public offering is being made only by means of a prospectus. When available, copies of the prospectus relating to the offering may be obtained from Leerink Partners LLC, Attn: Syndicate Department, 1301 Avenue of the Americas, 5th Floor, New York, New York 10019, by email at syndicate@leerink.com.

 This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Amanat Acquisition Corp

Amanat Acquisition Corp is a recently incorporated blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. While the Company may pursue an initial business combination in any business or industry, the Company intends to focus on healthcare or healthcare-related industries, which can benefit from the expertise and capabilities of the management team in order to create long-term shareholder value. The Company is sponsored by Amanat Sponsor Holdings LLC and is led by Dr. Sandeep C. Kulkarni, its Chairman of the Board, Dr. Pavan Cheruvu, its Director and Chief Executive Officer, and Mr. Nicholas Fernandez, its Chief Financial Officer. The Company’s Board of Directors also includes Ms. Rakhi Kumar, Mr. Brad Middlekauff, and Mr. Patrick Crutcher.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) including the gross proceeds of the IPO, the anticipated use of the net proceeds from the IPO and the search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or that the net proceeds of the offering will be used as indicated or that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Amanat Acquisition Corp, including those set forth in the Risk Factors section of Amanat Acquisition Corp’s registration statement and preliminary prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Amanat Acquisition Corp undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Nicholas Fernandez
Chief Financial Officer
153 Central Avenue
C/O 56
Westfield, NJ 07091
201-688-0364
amanatacquisition.com 


FAQ

What are the key details of the Amanat Acquisition Corp (NASDAQ: AMAN) IPO priced on May 19, 2026?

Amanat Acquisition Corp priced a $75 million IPO on May 19, 2026. According to Amanat Acquisition Corp, the offering includes 7,500,000 Class A ordinary shares at $10.00 per share, with trading on the Nasdaq Capital Market under ticker AMAN beginning the same day.

How many shares are included in the Amanat Acquisition (AMAN) IPO and at what price?

The IPO includes 7,500,000 Class A ordinary shares at $10.00 per share. According to Amanat Acquisition Corp, this totals $75 million, with an additional 45-day option for the underwriter to buy up to 1,125,000 more shares to cover any over-allotments.

When will Amanat Acquisition Corp (AMAN) shares start trading on Nasdaq and when is the IPO closing?

Amanat Acquisition Corp shares are expected to begin trading on Nasdaq on May 19, 2026. According to Amanat Acquisition Corp, the offering is expected to close on May 20, 2026, subject to customary closing conditions typical for initial public offerings.

What is the business purpose and sector focus of Amanat Acquisition Corp (NASDAQ: AMAN)?

Amanat Acquisition Corp is a special purpose acquisition company formed to complete a business combination. According to Amanat Acquisition Corp, it may target any sector but intends to focus on opportunities in healthcare or healthcare-related industries through mergers or similar transactions.

What is the underwriter over-allotment option in the Amanat Acquisition (AMAN) IPO?

The underwriter has a 45-day option to purchase up to 1,125,000 additional shares. According to Amanat Acquisition Corp, these Class A ordinary shares can be bought at the IPO price, less underwriting discounts and commissions, to cover any over-allotments in the offering.